Cargando…

Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series

BACKGROUND: Peyronie’s disease is a chronic inflammatory condition of the corpora cavernosa characterized by the formation of plaque in the tunica albuginea, which results in penile deformity. Conservative medical approaches encompass oral, topical, and physical treatment. Only two cases of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulis, Gianni, De Giorgio, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547413/
https://www.ncbi.nlm.nih.gov/pubmed/36207748
http://dx.doi.org/10.1186/s13256-022-03614-1
_version_ 1784805259931025408
author Paulis, Gianni
De Giorgio, Giovanni
author_facet Paulis, Gianni
De Giorgio, Giovanni
author_sort Paulis, Gianni
collection PubMed
description BACKGROUND: Peyronie’s disease is a chronic inflammatory condition of the corpora cavernosa characterized by the formation of plaque in the tunica albuginea, which results in penile deformity. Conservative medical approaches encompass oral, topical, and physical treatment. Only two cases of patients with Peyronie’s disease with complete plaque regression after treatment have been described in literature. CASE PRESENTATION: Case 1: A 50-year-old Caucasian man with penile pain and double penile curvature of 5° (left ventrolateral), palpable nodule, and normal penile rigidity. The patient underwent multimodal therapy (oral antioxidants + topical diclofenac gel). At follow-up after over 4 years of treatment, the patient no longer complained of any penile deformity or pain. Ultrasound examination did not show any plaque. Case 2: A 26-year-old Caucasian man with lateral-right penile curvature of 30° (previous congenital curvature of 15°), palpable nodule, and normal penile rigidity. The patient underwent multimodal therapy (oral antioxidants + topical diclofenac gel + penile injections/pentoxifylline). After 28 months of treatment, the patient presented a lateral right curve of 15° at follow-up, similar to the original congenital penile curvature. Ultrasound examination no longer showed any plaque. Case 3: A 36-year-old Caucasian man with penile pain and a complex penile curvature of 15° and 20° (left dorsolateral), palpable nodule, and normal penile rigidity. The patient underwent multimodal therapy (oral antioxidants + topical diclofenac gel + penile injections/pentoxifylline). At follow-up after 28 months of treatment, the patient presented a dorsal curve (10°) similar to the original congenital curvature. Penile palpation did not detect any nodules, and ultrasound no longer showed any plaque. CONCLUSIONS: This study demonstrates that our multimodal therapy is able to completely regress plaque, as demonstrated in our previously published article. Peyronie’s disease has the potential to be treated conservatively with good results. However, this method of treatment needs to be combined with accurate ultrasound assessment, performed using a sufficiently advanced machine by an experienced operator.
format Online
Article
Text
id pubmed-9547413
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95474132022-10-09 Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series Paulis, Gianni De Giorgio, Giovanni J Med Case Rep Case Report BACKGROUND: Peyronie’s disease is a chronic inflammatory condition of the corpora cavernosa characterized by the formation of plaque in the tunica albuginea, which results in penile deformity. Conservative medical approaches encompass oral, topical, and physical treatment. Only two cases of patients with Peyronie’s disease with complete plaque regression after treatment have been described in literature. CASE PRESENTATION: Case 1: A 50-year-old Caucasian man with penile pain and double penile curvature of 5° (left ventrolateral), palpable nodule, and normal penile rigidity. The patient underwent multimodal therapy (oral antioxidants + topical diclofenac gel). At follow-up after over 4 years of treatment, the patient no longer complained of any penile deformity or pain. Ultrasound examination did not show any plaque. Case 2: A 26-year-old Caucasian man with lateral-right penile curvature of 30° (previous congenital curvature of 15°), palpable nodule, and normal penile rigidity. The patient underwent multimodal therapy (oral antioxidants + topical diclofenac gel + penile injections/pentoxifylline). After 28 months of treatment, the patient presented a lateral right curve of 15° at follow-up, similar to the original congenital penile curvature. Ultrasound examination no longer showed any plaque. Case 3: A 36-year-old Caucasian man with penile pain and a complex penile curvature of 15° and 20° (left dorsolateral), palpable nodule, and normal penile rigidity. The patient underwent multimodal therapy (oral antioxidants + topical diclofenac gel + penile injections/pentoxifylline). At follow-up after 28 months of treatment, the patient presented a dorsal curve (10°) similar to the original congenital curvature. Penile palpation did not detect any nodules, and ultrasound no longer showed any plaque. CONCLUSIONS: This study demonstrates that our multimodal therapy is able to completely regress plaque, as demonstrated in our previously published article. Peyronie’s disease has the potential to be treated conservatively with good results. However, this method of treatment needs to be combined with accurate ultrasound assessment, performed using a sufficiently advanced machine by an experienced operator. BioMed Central 2022-10-08 /pmc/articles/PMC9547413/ /pubmed/36207748 http://dx.doi.org/10.1186/s13256-022-03614-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Paulis, Gianni
De Giorgio, Giovanni
Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series
title Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series
title_full Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series
title_fullStr Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series
title_full_unstemmed Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series
title_short Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series
title_sort patients with peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547413/
https://www.ncbi.nlm.nih.gov/pubmed/36207748
http://dx.doi.org/10.1186/s13256-022-03614-1
work_keys_str_mv AT paulisgianni patientswithpeyroniesdiseaseachievecompleteplaqueregressionaftermultimodaltreatmentwithantioxidantsacaseseries
AT degiorgiogiovanni patientswithpeyroniesdiseaseachievecompleteplaqueregressionaftermultimodaltreatmentwithantioxidantsacaseseries